An insider at United Therapeutics sold $5,650,415 worth of stock recently.

Oct 30, 2026, 6:11 PM ETPaperworkRead the original at marketscreener.com

Neutral

United Therapeutics reported an insider share sale, but the filing gives no identity or reason. It describes a routine disclosure and reports no change to the company's business, so the outlook is unchanged.

UTHR · United Therapeutics Corporation

AI read · Neutral

The AI's read

It concerns an insider's personal shares, not a reported change to United Therapeutics' products, sales, or finances. The sale could prompt questions, but the report calls it routine and gives no identity or reason. It reports no change to the business, so the filing alone does not change the company's outlook.

Get alerts for UTHR

Follow United Therapeutics Corporation (UTHR) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for UTHR

Free on the App Store and Google Play, or on the web.